The Annexure

News to 9 October 2026 ·

Desk›Fast Moving Consumer Goods› Godavari Biorefineries Ltd

Godavari Biorefineries Ltd

BSE 544279 · NSE GODAVARIB · ISIN INE497S01012 · Group B · Active

Fast Moving Consumer Goods › Fast Moving Consumer Goods › Diversified FMCG › Diversified FMCG

₹240.35

+0.44%

BSE close, 28 August 2026

Market cap

₹1,230.01 cr

5.1 cr shares · Micro cap

Free float

₹451.27 cr

as published

P/E · P/B

-364.2× · 3.15×

EPS ₹-0.66 · BV ₹76.30

FY25-26 rev / PAT

1,964.92 / 1.24

₹ cr, as filed

Filings, window

25

6 selected · 24%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹227.65 52-WK HIGH ₹353.50 ₹240.35 10% of range
Against 52-week high-32.0%
Against 52-week low+5.6%
Day change+0.44%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-0.66
Price / earnings-364.17×
Price / book3.15×
Book value — derived, price ÷ P/B₹76.30
Return on equity-0.87%
Operating margin0.00%
Net margin-3.93%

Consistency check

P/B ÷ P/E, which must equal ROE
-0.86%
ROE as published
-0.87%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 541.68 -21.27 -4.16 — -3.93%
Mar-26 · Q 562.11 52.41 10.24 16.85% 9.32%
FY25-26 1,964.92 1.24 0.24 5.31% 0.06%

Quarter on quarter

Revenue, quarter on quarter
-3.6%
Net profit, quarter on quarter
-140.6%

Disclosure profile 25 filings in the window

0 median 15.0 sector max 55 25 86th percentile of 384 Fast Moving Consumer Goods filers
Shaded is the middle half of the sector, 10 to 20 filings. Measured against the 384 Fast Moving Consumer Goods companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Change in Management1
Concall Transcript1
Investor Presentation1
Press Release1
Results1
Selected sub-total6
Procedural
General5
Analyst / Investor Meet4
AGM / EGM3
Newspaper Publication3
Annual Report1
Board Meeting1
Compliance Certificate1
Trading Window1
Procedural sub-total19
Total25

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

25 filings · 6 selected · busiest 2026-08-07

Filing rhythm · the twelve most recent

2026-08-272026-10-08

SelectedProcedural

Filings

25 in the window · 8 earlier on record

  1. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 2 October 2026 ·

    General

    Announcement Under Regulation 30- Patent

    The Mexican patent office has granted our patent application entitled 'Use of Compounds for Treating Viral Infections'

    Company Update / General View filing →

  3. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer Report alongwith Voting Results for the AGM held on September 28, 2026

    AGM/EGM / AGM View filing →

  4. 28 September 2026 ·

    Change in Management

    Change in Management

    Appointment/Re-appointment of Directors

    Company Update / Change in Management View filing →

  5. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of 71st AGM held on Monday, 28th September, 2026

    AGM/EGM / AGM View filing →

  6. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 23 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The company will officially participate in the Bharat Connect-Arihant Capital virtual conference

    Company Update / Analyst / Investor Meet View filing →

  8. 16 September 2026 ·

    General

    Announcement Under Regulation 30- Patent

    The China Patent Office granted a patent application entitled "Use of Compounds for Treating Viral Infections"

    Company Update / General View filing →

  9. 4 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    71st Annual Report for the FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  10. 4 September 2026 ·

    General

    Letter To Shareholders Of The Company As Per Regulation 36 (1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Letter to Shareholders of the Company as per Regulations 36 (1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / General View filing →

  11. 4 September 2026 ·

    AGM / EGM

    Notice Of 71St Annual General Meeting Of The Company To Be Held On Monday, 28Th September, 2026 At 11:30 A.M. Through VC/OVAM

    Notice of 71st Annual General Meeting of the Company to be held on Monday, 28th September, 2026 at 11:30 a.m. through VC/OVAM

    AGM/EGM / AGM View filing →

  12. 27 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copy of newspaper publication

    Company Update / Newspaper Publication View filing →

  13. 21 August 2026 ·

    General

    Announcement Under Regulation 30 - Shown Cause Notice

    The company received SCN from the Asst Commissioner of Central GCT

    Company Update / General View filing →

  14. 20 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication Regarding Special Window for Re-lodgement of Transfer Request of Physical Shares

    Company Update / Newspaper Publication View filing →

  15. 13 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of Earning Call held on 7th August, 2026

    Company Update / Earnings Call Transcript View filing →

  16. 11 August 2026 ·

    General

    Announcement Under Regulation 30- Patent

    The European Patent Office has granted our patent application titled "Pharmaceutical Composition and Process to Prepare the same"

    Company Update / General View filing →

  17. 7 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The official of the company will participate in a conference organised by the Emkay Global Financial Services Limited

    Company Update / Analyst / Investor Meet View filing →

  18. 7 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording of Q1 FY 27 investor call

    Company Update / Analyst / Investor Meet View filing →

  19. 7 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copy of newspaper publication of unaudited financial results for the quarter ended June 30, 2026

    Company Update / Newspaper Publication View filing →

  20. 7 August 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation Q1Fy27

    Company Update / Investor Presentation View filing →

  21. 5 August 2026 ·

    Press Release

    Press Release / Media Release

    Press Release for the Quarter ended June 30, 2026

    Company Update / Press Release / Media Release View filing →

  22. 5 August 2026 ·

    Results

    Unaudited Financial Results For The Quarter Ended 30Th June, 2026

    Unaudited Financial Results for the Quarter ended 30th June, 2026

    Result / Financial Results View filing →

  23. 5 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30Th June, 2026

    Unaudited Financial Results for the Quarter ended 30th June, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  24. 22 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Earnings Call for Q1FY27

    Company Update / Analyst / Investor Meet View filing →

  25. 21 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Quarter Ended On June 30, 2026.

    Godavari Biorefineries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Un-Audited Financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Godavari Biorefineries Ltd · the 50 most recent filings